Latest Post

Ex-Dragon Age lead gives The Veilguard’s first gameplay a thumbs up – “I’m just eager to see where this goes” Dave & Buster’s: Game On, Less Than 3x EBITDA (PLAY)


La prevención es la mejor medicina

bojanstory/E+ via Getty Images

Galectin Therapeutics Inc. (NASDAQ:GALT) is a biotechnology company focused on developing therapies that target galectin proteins related to conditions such as metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and cancer. Galectins, specifically galectin-3, are involved in inflammation, fibrosis, and tumor growth by binding to carbohydrates



Source link